Via di Campigliano,58 - 50012 - Località Ponte a Ema, Bagno a Ripoli-FI
For more than 50 years, bioMérieux's activities have been concentrated in the health sector and in particular in the development, production and marketing in more than 150 countries of instruments and reagents for clinical and microbiological testing in the pharmaceutical, cosmetic, food and environmental industries. In the Florence plant, bioMeriéux produces 3700 in vitro diagnostic instruments per year, among the most advanced on the market, with the most modern manufacturing technologies, through controlled and validated processes guaranteeing high quality standards. The Florence site is ISO 9001 and ISO 13485 certified and meets FDA requirements.
BioMérieux’s commitment to public health and expertise in biology are rooted in its unique family history. In 1897, Marcel Mérieux, a student of Louis Pasteur, founded an analysis laboratory in Lyon that would become Institut Mérieux. This marks the start of an extraordinary adventure in both biology and industry. In 1937, his son, Dr Charles Mérieux, took up the reins of his father’s laboratory. In the 1940’s, he introduced a technique developed by the Dutch Professor Frenkel - in vitro culture – which revolutionized the manufacture of vaccines and led to the production of reagents for in vitro diagnostic testing. In 1963, Alain Mérieux, grandson of Marcel, established the diagnostics company, bioMérieux. Today it is part of Institut Mérieux, whose companies in diagnostics, immunotherapy, food safety and nutrition, are working to meet the new challenges in public health and contribute to the medicine of tomorrow.
Immunoassay: based on an antigen/antibody reaction, immunoassay tests make it possible to detect infectious agents and quantify specific biomarkers. VIDAS®, bioNexia® and VIKIA® are bioMérieux’s main range names in this field.
Microbiology: VITEK®, VITEK® MS, API®, Previ® Isola, Previ® Color Gram, chromID® are just some of the ranges covering the detection, identification and susceptibility testing of microorganisms.
Molecular Diagnostics: bioMérieux’s molecular biology solutions cover extraction, amplification and detection. Technology now even enables us to take a syndromic approach and provide multiplex testing. Argene®, NucliSENS® easyMag, NucliSENS® easyQ, DiversiLab®, Filmarray™ are the main range names covering this domain.